Yes. GHK-Cu is a compounded prescription topical preparation requiring a valid prescription from a licensed healthcare provider. A telehealth consultation and medical intake are required before dispensing to confirm suitability and establish the appropriate use protocol.

GHK-Cu applied topically has an excellent established safety record. Mild skin sensitivity or temporary irritation may occur during initial use in patients with very reactive skin. The cream has a characteristic blue hue from the copper complex; this is normal, absorbs cleanly within seconds, and does not stain skin. If significant or persistent redness, rash, or swelling develops, discontinue and contact your provider.

Patients with known sensitivity or allergy to copper peptides or copper compounds should not use this product. Those with Wilson's disease or copper metabolism disorders should not use copper-containing topicals without specialist guidance. Patients with active eczema, rosacea flares, or significantly compromised facial skin should introduce GHK-Cu gradually. Safety during pregnancy and breastfeeding has not been established — consult your provider before use.

Concurrent use of copper-chelating topicals or systemic copper-chelating agents (D-penicillamine, trientine) may reduce GHK-Cu's activity. Patients using high-concentration retinoids, AHAs/BHAs, or strong oxidizing agents should discuss application sequencing and layering protocol with their provider to minimize potential barrier disruption. Discuss your full current skincare regimen before starting.

Patients with Wilson's disease or copper metabolism disorders require specialist assessment before using copper-containing topicals. Those with a history of malignancy should discuss use with their provider given GHK-Cu's gene-modulating and angiogenic properties. Patients with active inflammatory skin conditions should delay initiating treatment until skin is stable. Your provider will review your complete history before prescribing.